Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia

NCT ID: NCT05326607

Last Updated: 2022-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-09

Study Completion Date

2022-01-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a pilot clinical investigation of adaptive eyeglasses for the correction of presbyopia. The goal of this clinical investigation is to assess IMD safety and to obtain patient feedback on the usefulness of the Laclarée eyeglasses, through subjective clinical measures and qualitative evaluations. This is an exploratory investigation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Presbyopia is a visual impairment caused by the normal aging of the eye lens and resulting in progressive loss of accommodation. As a consequence, from the onset of presbyopia occurring around 40-45 years old, the eye has growing trouble focusing at near and intermediate distances. Millions of presbyopes encounter difficulties with current corrective solutions, leading to vision and postural discomfort. Laclarée's adaptive eyeglasses are providing an alternative solution, closer to the native crystalline accommodation. Besides an enhanced field-of-view, these eyeglasses offer a disruptive ergonomics where the glasses automatically adjust to the wearer's need to provide clear vision at all distances and can be electronically recalibrated to adjust the delivered addition throughout presbyopia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Presbyopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

First Arm

Group Type OTHER

Prototype of adaptive eyeglasses

Intervention Type DEVICE

The tested investigational medical device is a prototype of semi-integrated eyeglasses.

Comparator

Intervention Type DEVICE

The comparator is either a pair of progressive lenses that provide clear vision at both distance and near vision, either, for wearers who have rejected progressive glasses, an alternative solution providing clear vision at both distance and near vision which can consist of bifocal glasses, multifocal or monovision lenses, multiple pairs of glasses or one pair for cases of emmetropia.

Second Arm

Group Type OTHER

Prototype of adaptive eyeglasses

Intervention Type DEVICE

The tested investigational medical device is a prototype of semi-integrated eyeglasses.

Comparator

Intervention Type DEVICE

The comparator is either a pair of progressive lenses that provide clear vision at both distance and near vision, either, for wearers who have rejected progressive glasses, an alternative solution providing clear vision at both distance and near vision which can consist of bifocal glasses, multifocal or monovision lenses, multiple pairs of glasses or one pair for cases of emmetropia.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prototype of adaptive eyeglasses

The tested investigational medical device is a prototype of semi-integrated eyeglasses.

Intervention Type DEVICE

Comparator

The comparator is either a pair of progressive lenses that provide clear vision at both distance and near vision, either, for wearers who have rejected progressive glasses, an alternative solution providing clear vision at both distance and near vision which can consist of bifocal glasses, multifocal or monovision lenses, multiple pairs of glasses or one pair for cases of emmetropia.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient \>18 years of age, male or female who has given explicit informed consent (dated and signed)
2. Diagnosed with presbyopia
3. A wearer whose current corrective solution is a pair of progressive lenses that provide clear vision at both distance and near vision (worn at least 5 times per week for 4 hours per day), or, a wearer who has rejected progressive glasses that provide clear vision at both distance and near vision and who uses another corrective solution that provides clear vision at both distance and near vision (bifocal glasses, multifocal or monovision lenses, multiple pairs of glasses or one pair for cases of emmetropia)
4. Patient with a distance visual acuity of 10/10 at least with current corrective solution
5. Patient with a visual acuity of P2 at least in near vision with current corrective solution
6. Patient with at least 10/10 distance vision once corrected with contact lenses for the test
7. Inter-pupillary distance in distance vision between 55 and 71mm
8. Distance from temple-to-temple not exceeding 161mm
9. Addition greater than or equal to 1.75D: Add≥1.75D
10. Sphere strictly between -6D and +4D: -6D\<S\<+4D
11. Cylinder below 1.75D:C\<1.75D
12. Patient uses a computer (at least 3 times a week in private and/or work settings).
13. Affiliation to a social security scheme
14. French-speaking (fluent).
15. Patient willing to participate in the study.

Exclusion Criteria

1. Patient under tutorship or guardianship.
2. Patient unable to understand the study procedures and therefore to provide free and informed consent
3. Patient with reading difficulties
4. Patient with multifocal implants
5. Patient who has undergone multifocal surgery
6. Patient with prism correction
7. Patient with a current or past eye condition that may adversely affect vision
8. Patient being treated or having undergone surgery likely to adversely affect vision
9. Patient with mobility problems that would prevent tests and workshops from being carried out
10. Patient intolerant to wearing contact lenses for a few hours (only for presbyopes with ametropia)
11. Patient who is pregnant or breastfeeding
12. Patient already included once in the study
13. Patient placed in an institution based on a judicial or regulatory ruling, held in psychiatric department, in state-run prison, or employed by the study research sites or by the sponsor.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Iris Pharma

INDUSTRY

Sponsor Role collaborator

Laclaree

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruno BERGE, PhD

Role: STUDY_CHAIR

SPONSOR: LACLAREE

Jessica JAROSZ, PhD

Role: STUDY_DIRECTOR

SPONSOR: LACLAREE

Philippe GAIN, Prof.

Role: PRINCIPAL_INVESTIGATOR

CHU SAINT-ETIENNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Saint-Etienne Hôpital Nord, Service d'Ophtalmologie 25, boulevard Pasteur

Saint-Etienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Related Links

Access external resources that provide additional context or updates about the study.

https://opg.optica.org/oe/fulltext.cfm?uri=oe-27-8-10533&id=408132

Jessica Jarosz, Norbert Molliex, Guilhem Chenon, and Bruno Berge, "Adaptive eyeglasses for presbyopia correction: an original variable-focus technology," Opt. Express 27, 10533-10552 (2019)

https://doi.org/10.1117/12.2507816

Jessica Jarosz, Norbert Molliex, Quentin Lavigne, and Bruno Berge "An original low-power opto-fluidic engine for presbyopia-correcting adaptive eyeglasses", Proc. SPIE 10858, Ophthalmic Technologies XXIX, 1085824 (28 February 2019)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A00521-40

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smart Autofocusing Eyeglasses
NCT03911596 COMPLETED